Answers are grounded in this paper and cite their sources.
Keratoconus is increasingly recognised in children and adolescents, and early corneal cross-linking can halt its progression, but it remains unclear whether all children or only those with risk factors should be screened. Selected school-based, clinic-based and other population studies have reported prevalence estimates of approximately 0.4–2.7%, although differences in sampling, age distributions and diagnostic definitions limit direct comparisons. First-degree relatives show a high yield of keratoconus on corneal tomographic assessment, and Down syndrome is associated with increased prevalence, although the main registry estimate is not specific to children. Refractive astigmatism and its progression provide practical referral indicators, whereas atopy and eye rubbing do not currently define sufficiently narrow high-yield groups. The proportion of paediatric cases without recognised risk factors remains unknown. Test accuracy in unselected children, the natural history of screen-detected suspect disease and the comparative cost-effectiveness of screening strategies are also uncertain. Current evidence supports active case-finding in defined high-risk groups and corneal tomographic assessment in children with refractive warning signs. Universal screening should be evaluated in selected high-prevalence settings.
No takes yet. Share an insight, caveat, or question.
Dolar-Szczasny et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: